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ABSTRACT: Successful matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging (MSI) relies on the se-
lection of the most appropriate matrix and optimization of the matrix application parameters. In order to achieve reproducible high 
spatial-resolution imaging data, several commercially available automated matrix application platforms have become available. How-
ever, the high cost of these commercial matrix sprayers is restricting access into this emerging research field. Here, we report an 
automated platform for matrix deposition, employing a converted commercially-available 3D printer ($300) and other parts com-
monly found in an analytical chemistry lab alow-cost alternative to commercial sprayers. Using printed fluorescent rhodamine B 
microarrays and employing experimental design, the matrix deposition parameters were optimized to minimize surface analyte dif-
fusion. Finally, the optimized matrix application method was applied to image 3-dimensional MCF-7 cell culture spheroid sections 
(ca. 500 µm diameter tissue samples) and sections of mouse brain. Using this system, we demonstrate robust and reproducible obser-
vations of endogenous metabolite and steroid distributions with a high spatial resolution.
Introduction  
Over the last decade, MALDI mass spectrometry imaging 
(MSI) has become established as a powerful technique for ob-
serving the spatial distribution of small molecules,1 lipids,2 pep-
tides3 and proteins4 from the surface of a wide variety of sam-
ples. Using this technique, a spatial resolution of below 10 µm 
has been demonstrated.5–8 However, in order to achieve such 
robust high spatial resolution data, reproducible sample prepa-
ration is crucial. Each stage in the preparation workflow must 
be carefully optimized for the specific tissue or sample to main-
tain the true spatial distributions of the biomolecules and reduce 
inter-sample variability.9,10 During matrix application, analyte 
diffusion is a major concern, and the selection of the most ap-
propriate matrix and optimization of its application parameters 
is key to obtaining high quality and biologically relevant spectra 
directly from tissue samples.11 Subtle changes in application 
rate, drying times, matrix composition and area density all af-
fect the ionization efficiency, the propensity to detect low abun-
dance compounds and the reproducibility of the results ob-
tained.9 The matrix crystal dimensions produced also affect the 
lateral resolution of the image, thus optimization of matrix ap-
plication can produce a crystal size smaller than the diameter of 
the laser, making the laser beam the limiting factor in the imag-
ing resolution that can be achieved.9,11  
Matrix can be applied with or without the addition of sol-
vents. Solvent-free application can reduce analyte delocaliza-
tion, whilst solvents can increase the number of peaks observed, 
producing complementary biological information.12 Solvent-
based matrices can be applied either manually or using an auto-
mated robotic system, discretely as spots or continuously as a 
coating.11,13 During manual matrix application, the homogene-
ity of the matrix coverage and the crystal size often varies de-
pending on the operator whilst automated methods have been 
developed with the goal of removing inter-user variation.14 Au-
tomated sprayers remove the variability by controlling the tem-
perature, solvent flow rate, spray velocity and the number of 
passes; however, they are typically slower than the manual 
methods.12 A number of automated systems are commercially 
available, including the Bruker ImagePrep (Bremen, Germany), 
the SunChrom SunCollect (Friedrichsdorf, Germany) and the 
HTX-TM-Sprayer (HTX Technologies, LLC, NC, USA), how-
ever the cost of this equipment limits many research facilities’ 
accessibility to the technique.15 Several less expensive auto-
mated matrix application strategies have been developed in ac-
ademic research laboratories. These include, an automated 
acoustic spotter,13 the repurposing of an inkjet printer,16 and the 
use of an pneumatic sprayer on top of a pneumatically moveable 
base.15 These alternative printing nozzles apply different tech-
nologies to emit a spray of matrix capable of producing small 
uniform crystals suitable for MSI. Continuous inkjet (CIJ) 
printing is a low-cost method that pumps fluid through a nozzle 
 to eject a continuous stream of uniform droplets at high fre-
quency.17 The vibrations of a piezoelectric actuator determines 
the size of the droplets, generating droplets  around 40 µm in 
diameter, producing low resolution printing.17 To reduce the 
droplet size produced and increase the resolution, a number of 
drop-on-demand (DOD) printers have become commercially 
available, utilizing piezoelectric printing.18 This involves apply-
ing a voltage to alter the pulse duration and the diameter of the 
nozzle which then controls the size of the droplets.17 A disad-
vantage of this method is the high cost of the printer equipment 
required, as well as inkjet printers being prone to blockage of 
the nozzle. Alternatively, in the absence of a current, a pneu-
matic nebulizer works using induction to atomize the liquid us-
ing a gas stream and produces droplets of down to 0.1 µm.19 
This method requires a lower flow rate than the inkjet options, 
thus using less liquid.20  
In this paper, we report an automated method for matrix depo-
sition, employing a converted commercial 3D printer ($300) 
and other parts commonly found in an analytical chemistry lab 
as a cost-effective alternative to commercial sprayers. Using 
printed rhodamine B microarrays and fluorescence imaging, we 
quantitate the extent of diffusion during matrix application. 
Through the use of experimental design, key experimental pa-
rameters, including temperature, gas pressure and nozzle height 
were varied and the effect on analyte diffusion established. The 
optimization can be readily adapted for a range of similar de-
vices. After optimization, matrix deposition using this system 
effectively reduced analyte diffusion. To demonstrate the use of 
this equipment, the optimized matrix application method was 
applied to observe metabolite distributions in MCF-7 spheroid 
sections (ca. 500 µm diameter tissue samples) with a consist-
ently high spatial resolution. The reproducibility and efficacy 
of the matrix application platform across larger samples was 
shown using mouse brain tissue sections (ca. 20 mm diameter) 
and with alternative matrices. 
 
Experimental 
Adaptation of a commercial 3D printer to a MALDI matrix 
application platform and optimization of matrix application 
conditions. An i3 duplicator 3D printer (WANHAO, Zhejiang, 
China) with a temperature controlled build plate (0-120 oC) was 
used in this work. Adaptation of the printer takes half an hour, 
with all equipment costing a total of ca. $2600. See supplemen-
tary information for step-by-step instructions. Matrix deposi-
tion was achieved by replacing the printing extruder with a 
commercially available electrospray emitter for nebulization 
(Bruker Daltonics, Bremen, Germany).  ).  While comparatively 
expensive, a commercially available nebulizer was chosen as it 
is a robust device whose results can be replicated in other labor-
atories; and it will be commonly available in mass spectrometry 
laboratories.  In these experiments no electrospray voltage was 
applied to the nebulizer relative to the sample slide.  The x,y,z 
position and feed rate of the extruder is controlled with G-code 
instructions; a numerical control programme developed by 
Massachusetts Institute of Technology. The x,y positions were 
determined to cover the area of a slide, whilst the z height was 
determined as a distance between the emitter and the bed height. 
The z height was calibrated to 0 when the nebulizer was 2 mm 
above the bed. To convert the 3D printer, the printer’s extruder 
was removed and replaced with the nebulizer (Bruker Dalton-
ics, Bremen, Germany) mounted onto a spacer fabricated from 
poly lactic acid (PLA) plastic and produced by 3D printing (fig-
ure 1). The 3D printed spacer was designed using an online soft-
ware and converted to a .STL file for printing (see supplemen-
tary information for details). 
 
Figure 1. The printer extruder was removed and replaced with 
a (A) 3D printed block that held the (B) nebulizer in place. First, 
the (C) 3D block was screwed onto the structure and (D) subse-
quently the nebulizer held in place with a screw. 
Nitrogen was used as the nebulizer gas and set manually with 
an inline regulator. The nebulizer was connected to a nitrogen 
supply (70 psi) and the inlet of the sprayer was connected to a 
Rheodyne C1-2006 6 port valve (Valco Instruments, Texas, 
USA) using 100 µm internal diameter fused silica tubing (sup-
plementary figure 1). The valve was equipped with a 5 mL sam-
ple loop, through which matrix could be injected and subse-
quently sprayed onto the slide. A Shimadzu LC-10ad HPLC 
pump (Shimadzu, Milton Keynes, UK) was connected to the 6 
port valve at a flow rate of 0.1 mL/minute (figure 2). The matrix 
solution and application solvent used was 70:30 (v/v) acetoni-
trile: water. The mass of matrix deposited by the optimized 
method on the commercial TM-sprayerTM (HTX Technologies, 
LLC, NC, USA) was 2 mg. Therefore, the feed rate of the spray 
head and the flow rate of the solvent were optimized to match 
this area density. The velocity was set within the G-code as 
F1000, which resulted in a velocity of 1100 mm/minute. The 
total time taken for 8 passes of a glass slide was 25 minutes. For 
consistent performance, regular wash cycles were done with 
solvent before and after use. 
 Figure 2. Outline of the printer setup. (A) The 3D printer used was the WANHAO Duplicator i3. (B) The extruder and fans were 
removed to leave the extruder housing block and remaining wires were insulated and secured in place with electrical tape. (C) A 3D 
printed block and nebulizer were secured in place and connected to a gas line and a 6-port HPLC valve with a 5 mL loop and a waste 
line. (D) An HPLC pump was connected and a solution of 70:30 (v/v) acetonitrile: water and a flow rate of 0.1 mL/minute was used 
during matrix application. 
Generation and matrix coating and fluorescence imaging of 
rhodamine B microarrays. 45 spots containing 50 droplets of 
350 pL 0.01% rhodamine B (w/v) in water (Sigma-Aldrich, 
Missouri, USA) were dispensed onto a SuperFrostTM glass slide 
using a SciFLEXARRAYER S5 microarray printer (Scienion 
AG, Berlin, Germany) equipped with a PDC 80 dispense capil-
lary (Piezo Systems, Massachusetts, USA) with a 50 µm nozzle 
aperture. HPLC-grade water used as the SciFLEXARRAYER 
solvent and was degassed preceding printing by sonication (30 
minutes). The fluorescence was measured using a BioAnalyzer 
4F/4S (LaVision BioTec, Bielefeld, Germany) fluorescence 
scanner at 70 ms exposure time using a Cy5 filter. The area of 
observed fluorescence was measured using the circle area se-
lection tool on ImageJ before and after matrix application. The 
standard deviation across the 45 spots was calculated before and 
after matrix application. 5 mg/mL 9-aminoacridine (9AA) in 
70:30 (v/v) acetonitrile: water was used as the matrix with the 
exact parameters outlined in the discussion. A flow rate of 0.1 
mL/minute and nozzle velocity of 1100 mm/minute was used 
for both the printer and commercial TM-sprayerTM. 
Scanning electron microscopy. The matrix-coated rhodamine 
B slides were mounted on aluminium stubs with carbon tabs at-
tached and sputter coated with 20 nm gold palladium (Emscope, 
Island Scientific, Ventnor, UK). The samples were viewed us-
ing a Hitachi S-4700 scanning electron microscope (Tokyo, Ja-
pan). 
Cell culture and spheroids preparation. MCF-7 cells were 
donated at passage 52 from the Queen’s Medical Research In-
stitute (QMRI), Edinburgh (UK). Both monolayer cells and 
spheroids were grown in Dulbecco’s Modified Eagles Medium 
(DMEM) (Thermo-Fisher, Massachusetts, USA) supplemented 
 with 10% fetal calf serum (FCS) (Sigma Aldrich, Missouri, 
USA) and 1% penicillin (Thermo-Fisher, Massachusetts, USA). 
Monolayer cells were routinely seeded every 4 days in 75 cm3 
flasks with 1 mL cells and 9 mL fresh media. The media was 
replaced every 48 hours. 
Spheroids were obtained using the hanging drop method.21 Ap-
proximately 6000 cells were seeded into 20 µL droplets that 
were then suspended from the lid of a petri dish. A reservoir of 
10 mL media was placed in the bottom of the dish. Spheroids 
were fed with 5 µL fresh media every 48 hours. Spheroids were 
incubated at 36.5 °C, 5% CO2 and 95% humidity for 8 days be-
fore imaging. 
MALDI imaging sample preparation 
Sample preparation of spheroids. 8 day old untreated MCF-7 
spheroids were prepared using the following method. Media 
was removed and spheroids were washed with ammonium for-
mate (20 µL, 50 mM). Each spheroid was picked up and placed 
into a droplet from which maximal liquid was removed. Blue 
dyed gelatin (40 µL, 10% w/v) was placed onto the spheroids 
and frozen on isopentane and dry ice (2 minutes). The gelatin 
blocks were then snap frozen in liquid nitrogen and stored (-80 
°C) until sectioning. Sectioning was performed using a cryostat 
(-21 oC) (Leica CM 1900 (Leica Biosystems, Nussloch, Ger-
many). Sections (15 µm) were cut and thaw mounted onto con-
ductive indium tin-oxide (ITO)-coated glass slides (Bruker Dal-
tonics, Bremen, Germany). Consecutive sections were taken for 
haematoxylin and eosin staining. 
Sample preparation of mouse brain: Licensed procedures 
were performed under the UK Animals (Scientific Procedures) 
Act, 1986. C57BL/6 mice (6–7 weeks, male) were from Harlan 
Olac Ltd. (Bicester, UK). Animals were killed by decapitation 
at 09:00 h. Brain tissue was snap frozen in liquid nitrogen and 
stored (−80 °C) until MSI analysis. Tissue sectioning was 
adapted from Cobice et al.22 Briefly, sectioning was performed 
using a cryostat (Leica Microsystems Inc., Bannockburn, IL, 
USA) and gelatin solution (10% w/v) as embedding media. Sag-
ittal brain sections (10 μm) were cut and thaw mounted onto 
conductive ITO-coated glass slides (Bruker Daltonics, Bremen, 
GmbH) pre-coated with GirT-reagent (0.15 mg/cm2). Tissue 
sections were stored in a vacuum desiccator (RT, 1h) and then 
at −80 °C until MSI analysis. 
Matrix application of MCF-7 spheroids. The matrix solution 
was 5 mg/mL of 9AA in 70:30 (v/v) acetonitrile: water. For the 
commercial sprayer, the TM-sprayerTM (HTX Technologies, 
LLC, NC, USA) was used to apply 8 coats of matrix at a flow 
rate of 0.1 mL/minute at 80 °C with a gas pressure of 10 psi and 
a velocity of 1100 mm/minute. Matrix area density was 0.11 
mg/cm2. The optimized converted 3D printer was used to apply 
8 coats of matrix at a flow rate of 0.1 mL/minute at 40 °C with 
a gas pressure of 50 psi and a z height of 30 mm. The velocity 
was set within the G-code as F1000, which resulted in a velocity 
of 1100 mm/minute. Matrix area density was 0.11 mg/cm2. 
Matrix application of mouse brain: The matrix solution was 
10 mg/mL of α-cyano-4-hydroxycinnamic acid (CHCA) in 
60:40 (v/v) acetonitrile: water with 0.1% TFA. The velocity was 
set within the G-code as F800, which resulted in a velocity of 
800 mm/minute. The total time taken for 4 passes of a glass 
slide was 20 minutes. For consistent performance, regular wash 
cycles were done with solvent before and after use. Matrix area 
density was 0.22 mg/cm2. 
Mass spectrometry imaging. A 12T SolariX FT-ICR MS 
(Bruker Daltonics, Bremen, Germany) equipped with a MALDI 
ionization source was operated in negative ionization mode to 
acquire spectra between 98-1500 m/z. The laser raster incre-
ment was set to 40 µm along both the x and y axis with a smart 
walk of 50 µm. Laser focus was set to minimum, with a fre-
quency of 1000 Hz. Ions were accumulated across 300 laser 
shots for each mass analysis. For mouse brain analysis, source 
was operated in positive ionization mode to acquire spectra be-
tween 250-2500 m/z. The laser raster increment was set to 75 
µm along both the x and y axis with a smart walk of 50 µm. 
Laser focus was set to small, with a frequency of 1000 Hz. Ions 
were accumulated across 300 laser shots for each mass analysis. 
Calibration of the spheroid data was performed post-processing 
using a pre-determined list of internal calibrants (supplemen-
tary information table 1). The images were then analyzed with-
out normalization using FlexImaging 4.1 (Bruker Daltonics, 
Bremen, Germany) and discriminatory analysis completed us-
ing SCiLS (Bruker Daltonics, Bremen, Germany). The metab-
olites were identified using the Human Metabolome Database 
(HMDB) using an error tolerance of 10 ppm for [M-H]-. 
(http://www.hmdb.ca/spectra/ms/search). 
H&E Staining. Sectioned spheroids were placed onto a glass 
slide and stored in a vacuum desiccator (RT, 18h) Cells were 
first washed with water. Sections were covered with haematox-
ylin (Sigma-Aldrich, Missouri, USA) (3 minutes) and washed 
with running water. The slide was coated with tap water (1 mi-
nute), then acid alcohol (Sigma-Aldrich, Missouri, USA) (20 
seconds) and then washed using water. Eosin (Sigma-Aldrich, 
Missouri, USA) was added (1 minute) and then washed with 
water. The stained cells were then air dried before being imaged 
under the 40X objective on an inverted AE2000 (Motic, Hong 
Kong) microscope.   
Results and Discussion 
Optimization of MALDI matrix application using rhoda-
mine B microarrays. Delocalization during matrix application 
was measured using microarrays of rhodamine B spots (0.01 % 
w/v) printed on glass slides. Rhodamine B is a water-soluble 
fluorescent dye which provided a model of low molecular 
weight metabolites that commonly delocalize in MALDI MSI. 
45 individual spots per slide provided a high number of tech-
nical repeats to produce statistically robust data for assessing 
the extent of delocalization. Each slide was coated with a 
MALDI matrix (9AA) using the 3D-printer platform and the 
average change in area was calculated. To identify the optimal 
matrix application conditions for minimizing delocalization, a 
user defined experimental design was compiled using Design 
Expert 10 (Stat-Ease, Minneapolis, USA) with discrete incre-
ments of 10 for 3 matrix application variables: nebulizing gas 
pressure (40-60 psi), build-plate temperature (20-40 °C) and 
nebulizer z height (i.e. height of nebulizer above the sample sur-
face) (10-30 mm). No voltage was applied as the nebulizer was 
used for nebulization. This process produced a set of 27 discrete 
conditions for matrix application. A slide of 45 replicate rhoda-
mine B spots was coated using each of the 27 defined condi-
tions. The change in area of fluorescence before and after ma-
trix application was recorded using a BioAnalyzer 4F/4S (LaV-
ision BioTec, Bielefeld, Germany) fluorescence scanner and 
 measured using ImageJ, In order to quantitate analyte diffusion 
as a consequence of matrix application, the average area change 
in fluorescence area after matrix coating was calculated (figure 
3 and supplementary information table 2).  
 
Figure 3. A bubble plot showing how the 27 matrix application 
conditions affect the change in area of rhodamine B fluores-
cence. The size of the circle is the percentage change in area of 
fluorescence after matrix application (diffusion) and the dark to 
pale blue color scale represents increasing gas pressure.  
By comparing the data collected over all the conditions tested, 
it can be seen that increasing both the z height and temperature 
reduced the extent of rhodamine B delocalization (supplemen-
tary figure 2). In contrast, varying the gas pressure had a lesser 
effect on the delocalization. The optimized parameters of 40 °C 
build-plate temperature, 30 mm nebulizer z height and 50 psi 
gas pressure produced a dry matrix application with a 9.44 % 
change in fluorescence area after matrix application. In contrast, 
the worst conditions were identified as 20 °C, 10 mm z height 
and 60 psi gas pressure, producing a 403 % increase in area of 
rhodamine B with visible smearing of the rhodamine B spots 
after matrix application (figure 4).  
 
Figure 4. Rhodamine B spots (0.01 % w/v, 17.5 µL) were spot-
ted using a microarray printer, and the fluorescence imaged at 
70 ms exposure. The change in area was measured for all 27 
conditions tested. Here the images of the optimized (A, 40 °C, 
30 mm, 50 psi) and worst (B, 20 °C, 10 mm, 60 psi) conditions 
before and after matrix application are shown. Scale bar 1 mm.  
Imaging the MALDI matrix crystal size using scanning elec-
tron microscopy. The crystal size produced during matrix ap-
plication defines the spatial resolution and the extent of analyte 
diffusion.11 By reducing the crystal size, a greater spatial reso-
lution is achieved.9 To assess the size of the matrix crystals, 
scanning electron microscopy (SEM) was used. Crystal size on 
the rhodamine printed slides was determined for both the opti-
mized and worst parameters for the modified 3D printer plat-
form, as well as for our laboratory’s standard application proto-
col using a commercially available system (the HTX TM-
sprayer) (figure 5). SEM images revealed that the worst condi-
tions produced a coverage of large heterogeneous crystals. In 
contrast, the optimized conditions produced a homogenous 
coating of small regularly-sized crystals across the sample 
which were comparable to that of the commercial printer.  
 
Figure 5. Scanning electron microscope images of the crystals 
produced under the (A) worst 3D printer conditions (B) opti-
mized 3D printer conditions and (C) optimized commercial 
HTX TM-sprayer conditions. The worst conditions produced 
large inhomogeneous crystals whilst the optimized method pro-
duced small crystals with a uniform coverage that were similar 
to those observed using the commercial sprayer.  
MALDI imaging of metabolites in tissue. Multicellular tumor 
spheroids (MTS) are spherical self-assembled cell cultures that 
grow up to 1 mm in diameter and are the most commonly used 
3D model for assessing drug penetration and efficacy ex 
vivo.23,24 MTS are known to have a diffusion limit of 150 - 200 
µm to molecules including oxygen, glucose and other metabo-
lites, above which the inefficient mass transport causes meta-
bolic waste accumulation and gradients of nutrients and waste 
products.25,26 A number of groups have used MSI to observe the 
distribution of proteins27 and drugs28 within spheroids. However 
due to their small size any delocalization caused by matrix ap-
plication can greatly affect the biological validity of the results 
obtained. Based on the optimal conditions obtained through ex-
perimental design, MCF-7 spheroids were sectioned and subse-
quently imaged using MALDI FT-ICR MS at 40 µm imaging 
resolution. These sub-1 mm tissues provide an effective model 
to understand the spatial distribution of molecules in small sys-
tems. The resulting MSI data achieved using the optimized and 
non-optimal 3D printer matrix application conditions were 
compared to the current laboratory standard protocol using a 
HTX-TM sprayer. Figure 6 shows the distribution of a number 
of metabolites including glutathione, adenosine triphosphate 
(ATP) and adenosine monophosphate (AMP) throughout the 
spheroid beside an optical image of an adjoining H&E stained 
section to validate the spheroid morphology after cryosection-
ing. Without optimization, the home-built matrix sprayer pro-
duced extensive diffusion of molecules including glutathione. 
This resulted in the analytes diffusing out of the tissue and into 
the embedding medium, producing a biologically inaccurate 
 distribution. The nebulizer was located near the sample at a high 
gas pressure without a heated bed. Under these lower tempera-
ture conditions, crystals form more slowly and therefore pro-
duce larger heterogeneous distributions, incorporating analytes 
across larger regions with a poor signal-to-noise ratio for the 
analytes observed.9 However, through optimization of the 
home-built matrix sprayer, including increasing the z height of 
the nebulizer and increasing the temperature of the heated bed, 
the distributions resembled those observed under the optimized 
conditions of a commercially available sprayer, with a number 
of analytes having an improved signal from that observed using 
the commercial sprayer. Glutathione was observed to entirely 
delocalize outside of the spheroid prior to the home-built matrix 
sprayer optimization, however under the optimized conditions 
it localized towards the centre of the spheroid, similarly to that 
observed using the commercially available sprayer. A similar 
distribution was observed for the oxidized form of glutathione. 
In contrast, ATP distributed to the outer region of the spheroid 
under all spraying conditions. The most noticeable difference as 
a result of the optimization is the distribution of AMP. After 
optimization, AMP appears uniformly distributed, suggesting 
that the localization to the outer part of the spheroid that is ob-
served using non-optimized matrix deposition is an artefact 
caused by analyte delocalization. Importantly, these distribu-
tions were reproducibly observed using both the commercially 
available sprayer and the 3D printer (supplementary figure 3).
 
Figure 6. MCF-7 spheroids were imaged at 40 µm lateral laser resolution using the FT-ICR MS. Distributions of molecules were 
observed and compared between the non-optimized and optimized parameters of the 3D printer compared to that of the current 
protocol using a commercially available sprayer. The H&E sections are shown to confirm the morphology of the cryosectioned 
spheroids. 
To further demonstrate the reproducibility and efficacy of the 
matrix coater over a larger area and with alternative matrices, 
the 3D printer was used to coat sections of mouse brain with 
CHCA. The sample was imaged at 75 µm lateral laser resolu-
tion using FT-ICR MS (figure 7). The spatial distributions of 
two endogenous steroids, derivatized with Girard’s reagent T 
(as described previously (22)) were determined (figure 7B and 
Fig 7C). The observed distributions closely matched previously 
reported results.22 Importantly, the spatial distribution of the 
data was consistent throughout the ~20 mm tissue section, with 
clear partitioning of the endogenous steroids throughout the tis-
sue. These observations confirm the consistency of matrix dep-
osition using our matrix application platform.  
  
Figure 7. The 3D printer was used to coat sections of mouse brain with CHCA as the matrix.  The spatial distributions of two endog-
enous steroids were observed and found to closely match previously reported results.22 Tissue was imaged at 75 µm lateral laser 
resolution using the FT-ICR MS. (A) optical image of sagittal cryosection of murine brain, (B) MSI heat map of Corticosterone 
derivative (GirT-CORT) at m/z 460.3171 ± 0.002 Da, (C) 11-dehydrocorticosterone (GirT-11DHC) at m/z 458.2998 ± 0.002 Da and 
(D) MSI images superimposition of corresponding steroids derivatives. Signal intensity is depicted by colour on the scale shown. 
Scale bar (5 mm).  
Conclusion 
Here we have shown that a 3D printer can be converted into an 
effective automated MALDI matrix applicator which operates 
with minimal analyte diffusion during matrix application. Using 
fluorescent microarrays and experimental design the conditions 
for 9AA matrix application were optimized. With a heated bed 
and an increased z height of the sprayer, it was possible to min-
imize sample wetting and therefore reduce analyte diffusion. 
These optimized conditions could then be used to reproducibly 
image MCF-7 spheroids and identify numerous metabolites 
with reduced analyte delocalization. This produced images with 
comparable distributions to those observed using a commer-
cially available printer at a fraction of the set-up cost compared 
to commercially available systems. The efficacy of the device 
was further demonstrated over larger areas and with alternative 
matrices by imaging a mouse brain coated with CHCA. As a 
result, initial findings shown here demonstrate the potential ap-
plication of this system for effective MALDI matrix application 
to biological tissue sections, thus enabling reliable low-cost 
high-resolution MSI. 
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